Publicaciones (77) Publicaciones de JESÚS PÉREZ LOSADA

2024

  1. Immunosuppression is associated with an increased risk of distant metastases in high-risk cutaneous squamous cell carcinoma: A retrospective cohort study

    JAAD International, Vol. 15, pp. 74-77

2023

  1. Artificial intelligence-empowered cellular morphometric risk score improves prognostic stratification of cutaneous squamous cell carcinoma

    Clinical and Experimental Dermatology

  2. Cutaneous squamous cell carcinoma: From biology to therapy

    Advances in Surgical and Medical Specialties (Taylor and Francis), pp. 393-424

  3. Identification of Genomic Regions Implicated in Susceptibility to Schistosoma mansoni Infection in a Murine Backcross Genetic Model

    International Journal of Molecular Sciences, Vol. 24, Núm. 19

  4. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

  5. Pan-cancer evaluation of clinical value of mitotic network activity index (MNAI) and its predictive value for immunotherapy

    Frontiers in Oncology, Vol. 13

  6. TMeB score may improve risk stratification of high-risk cutaneous squamous cell carcinoma and guide management of patients: A pilot study

    Journal of the European Academy of Dermatology and Venereology

  7. The Role of GAB1 in Cancer

    Cancers, Vol. 15, Núm. 16

2022

  1. Chloroquine-Induced DNA Damage Synergizes with Nonhomologous End Joining Inhibition to Cause Ovarian Cancer Cell Cytotoxicity

    International Journal of Molecular Sciences, Vol. 23, Núm. 14

  2. Evolutionary Origins of Metabolic Reprogramming in Cancer

    International journal of molecular sciences, Vol. 23, Núm. 20

  3. From Mouse to Human: Cellular Morphometric Subtype Learned From Mouse Mammary Tumors Provides Prognostic Value in Human Breast Cancer

    Frontiers in Oncology, Vol. 11

  4. Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer

    Cancers, Vol. 14, Núm. 2

2021

  1. Distinct clinical impact and biological function of angiopoietin and angiopoietin-like proteins in human breast cancer

    Cells, Vol. 10, Núm. 10

  2. Overcoming resistance to immunotherapy in advanced cutaneous squamous cell carcinoma

    Cancers, Vol. 13, Núm. 20

  3. Viruses and skin cancer

    International Journal of Molecular Sciences, Vol. 22, Núm. 10

2020

  1. Cutaneous squamous cell carcinoma: From biology to therapy

    International Journal of Molecular Sciences, Vol. 21, Núm. 8

  2. Stromal SNAI2 is required for ERBB2 breast cancer progression

    Cancer Research, Vol. 80, Núm. 23, pp. 5216-5230

2019

  1. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice

    Journal of the American Academy of Dermatology, Vol. 80, Núm. 1, pp. 106-113.e2

  2. MicroRNA dysregulation in cutaneous squamous cell carcinoma

    International Journal of Molecular Sciences, Vol. 20, Núm. 9

2018

  1. FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy

    Molecular Oncology, Vol. 12, Núm. 6, pp. 883-895